> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Cancer Trial Placebo Use & Blinding
- URL: https://www.fdaweb.com/guide-on-cancer-trial-placebo-use-blinding/
- Published: 2019-08-29T12:00:00.000Z
- Updated: 2026-09-15T01:46:57.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144889

*Federal Register* notice: FDA has made available a final guidance entitled “Placebos and Blinding in Randomized Controlled Cancer Clinical Trials for Drug and Biological Products.” The document finalizes an 8/24 draft guidance entitled “Hematologic Malignancy and Oncologic Disease: Considerations for Use of Placebos and Blinding in Randomized Controlled Clinical Trials for Drug Product Development.” To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-08-29/pdf/2019-18715.pdf?ref=fdaweb.com).